Documents

Salmeterol/Fluticasone STADA 25 μg/50 μg/dose, 25 μg/125 μg/dose and 25 μg/250 μg/dose, aerosol, suspension - public assessment report refusal of application

Publication | 26-08-2013

Xylometazoline HCl/Dexpanthenol 0.5/50 mg/ml and 1.0/50 mg/ml ratiopharm, nasal spray, solution - public assessment report withdrawn application

Publication | 26-06-2013

Disinfectant products: Distinguishing between biocidal products and medicinal products (human and veterinary)

Policy document | 01-05-2013

Second assessment of methylcellulose, applicant Dow Wolff Cellulosics

A report on the second assessment of methylcellulose, by the company Dow Wolff Cellulosics.

Report | 29-03-2013

Second assessment of Rapeseed protein, applicant Bioexx Specialty Proteins

A report on the second assessment of rapeseed protein, by the company Bioexx Specialty Proteins.

Report | 03-12-2012

Second assessment of UV-treated bakers yeast, applicant Lallemand

A report on the second assessment of UV-treated bakers yeast, by the company Lallemand.

Report | 09-11-2012

MEB 9: Objection procedure

Download this policy document in English or in Dutch.

Policy document | 05-11-2012

Melatonin TioFarma 1, 3 and 5mg tablets - public assessment report withdrawn application

Publication | 29-06-2012

Second assessment of Oil rich in docosahexaenoic acid and eicosapentaenoic acid, applicant Martek Biosciences Corporation

A report on the second assessment of oil rich in docosahexaenoic acid and eicosapentaenoic acid, by the company Martek ...

Report | 24-02-2012

Second assessment of Rooster combs extract, applicant Bioiberica SA

A report on the second assessment of rooster combs extract, by the company Bioiberica SA.

Report | 06-01-2012